Forum: English - RussianThreads started by telce1

2	107	justify unaltered continuation  pharm.	telce1	14.07.2009	9:28
1	120	front line therapy  pharm.	telce1	13.07.2009	14:33
2	89	also had a case reported  pharm.	telce1	13.07.2009	14:29
2	100	European Union Annual Safety Report  pharm.	telce1	13.07.2009	11:21
9	909	executive summary  pharm.	telce1	13.07.2009	10:54
1	69	equivalent resistor  med.	telce1	1.07.2009	19:35
2	88	net filtration  med.	telce1	1.07.2009	18:16
1	70	exposed to pure  med.	telce1	1.07.2009	16:41
7	112	mercurial compound  pharm.	telce1	12.06.2009	9:14
1	644	potassium ethylparaben  perf.	telce1	12.06.2009	8:38
5	217	imaging follow-up  med.	telce1	4.06.2009	4:41
2	134	typical vascular pattern  med.	telce1	3.06.2009	22:32
3	113	at 3 month interval  med.	telce1	3.06.2009	22:15
	53	transmittral doppler  med.	telce1	24.05.2009	20:54
2	103	ICS, MCL, METS  med.	telce1	24.05.2009	10:47
8	506	sxs  med.	telce1	24.05.2009	6:38
1	100	systemic inquiry was noncontributory  med.	telce1	23.05.2009	20:55
1	95	genetlemen is a known  med.	telce1	23.05.2009	14:37
7	3594	Ethical Review Committees  pharm.	telce1	21.05.2009	18:25
2	202	confidential communication  pharm.	telce1	18.05.2009	15:45
1	81	Aerosol administration of interferon  med.	telce1	12.05.2009	13:56
3	84	the most commonly encountered  med.	telce1	12.05.2009	13:26
2	137	Segment I studies  med.	telce1	2.05.2009	15:18
1	183	AMENDMENT CHANGE  med.	telce1	2.05.2009	9:49
1	186	medium patient load  med.	telce1	30.04.2009	15:01
1	72	Standard Radiography Room  med.appl.	telce1	29.04.2009	12:53
3	469	well-established use application  med.	telce1	19.04.2009	14:21
	141	boundary  stat.	telce1	8.04.2009	16:02
2	136	stopping boundary  pharm.	telce1	8.04.2009	14:02
	47	risk factor with 2 modalities  stat.	telce1	7.04.2009	18:22
1	97	preference based measurement tool  pharm.	telce1	7.04.2009	15:51

Pages 1 2